Literature DB >> 31414918

The applications of metabolomics in the molecular diagnostics of cancer.

Pro Kit Cheung1, Man Hin Ma1, Hing Fung Tse1, Ka Fai Yeung1, Hin Fung Tsang1, Man Kee Maggie Chu2, Chau Ming Kan1, William Chi Shing Cho3, Lawrence Bo Wah Ng4, Lawrence Wing Chi Chan1, Sze Chuen Cesar Wong1.   

Abstract

Introduction: Metabolomics, the study of metabolites, is a promising research field for cancers. The metabolic pathway in a tumor cell is different from a normal tissue cell. There are two approaches to study the metabolism, targeted and untargeted. The general approach is that metabolomic data are interpreted by bioinformatics tools correlating with metabolomic databases to obtain significant findings. With the use of specific analysis tools, such as nuclear magnetic resonance (NMR) and mass spectrometer (MS) combined with chromatography, metabolic profile or metabolic fingerprint of various biological specimens could be obtained. The applications of metabolomics are used to discover potential cancer biomarkers and monitor the metastatic state, therapeutic and drug response for better patient management. Areas covered: In this review, the author introduce metabolomics and discuss the use of metabolomics approaches in different cancers, including the study of colorectal cancer, prostate cancer, liver cancer, pancreatic cancer and breast cancer using NMR and MS. Expert opinion: Knowledge on the molecular basis of cancer metabolism and its potential clinical applications has been improving recently. However, there are still many challenges for the technological development and integration of metabolomics with other omics spaces such as genomics. In the near future, it is expected that metabolomics will play an important role in cancer molecular diagnostics.

Entities:  

Keywords:  MS; Metabolomics; NMR; cancer; metabolite profiling; molecular diagnostics; pharmacometabolomics; precision medicine

Mesh:

Year:  2019        PMID: 31414918     DOI: 10.1080/14737159.2019.1656530

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  15 in total

Review 1.  Metabolomics: The Stethoscope for the Twenty-First Century.

Authors:  Hutan Ashrafian; Viknesh Sounderajah; Robert Glen; Timothy Ebbels; Benjamin J Blaise; Dipak Kalra; Kim Kultima; Ola Spjuth; Leonardo Tenori; Reza M Salek; Namrata Kale; Kenneth Haug; Daniel Schober; Philippe Rocca-Serra; Claire O'Donovan; Christoph Steinbeck; Isaac Cano; Pedro de Atauri; Marta Cascante
Journal:  Med Princ Pract       Date:  2020-12-03       Impact factor: 2.132

2.  Urinary Metabolic Profiling via LC-MS/MS Reveals Impact of Bovine Lactoferrin on Bone Formation in Growing SD Rats.

Authors:  Yan Xu; Tianyu Zhao; Haowei Ren; Yindan Xie; Jingjing An; Jiaqi Shang; Dina Tabys; Ning Liu
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

3.  Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.

Authors:  Ariadna Martín-Blázquez; Cristina Jiménez-Luna; Caridad Díaz; Joaquina Martínez-Galán; Jose Prados; Francisca Vicente; Consolación Melguizo; Olga Genilloud; José Pérez Del Palacio; Octavio Caba
Journal:  Cancers (Basel)       Date:  2020-04-18       Impact factor: 6.639

4.  Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal.

Authors:  Dawei Yang; Xiaofang Yang; Yang Li; Peige Zhao; Rao Fu; Tianying Ren; Ping Hu; Yaping Wu; Hongjun Yang; Na Guo
Journal:  J Transl Med       Date:  2020-06-17       Impact factor: 5.531

5.  Analysis of biomarkers and metabolic pathways in patients with unstable angina based on ultra‑high‑performance liquid chromatography‑quadrupole time‑of‑flight mass spectrometry.

Authors:  Yuechen Liu; Yue Li; Tianpu Zhang; Huan Zhao; Simiao Fan; Xuemeng Cai; Yijia Liu; Zhu Li; Shan Gao; Yubo Li; Chunquan Yu
Journal:  Mol Med Rep       Date:  2020-09-02       Impact factor: 2.952

6.  Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer.

Authors:  Leticia Díaz-Beltrán; Carmen González-Olmedo; Natalia Luque-Caro; Caridad Díaz; Ariadna Martín-Blázquez; Mónica Fernández-Navarro; Ana Laura Ortega-Granados; Fernando Gálvez-Montosa; Francisca Vicente; José Pérez Del Palacio; Pedro Sánchez-Rovira
Journal:  Cancers (Basel)       Date:  2021-01-05       Impact factor: 6.639

7.  Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography-Mass Spectrometry-Based Metabolomics.

Authors:  Chengnan Fang; Hui Wang; Zhikun Lin; Xinyu Liu; Liwei Dong; Tianyi Jiang; Yexiong Tan; Zhen Ning; Yaorui Ye; Guang Tan; Guowang Xu
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

Review 8.  Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go.

Authors:  Ruggero De Maria Marchiano; Gabriele Di Sante; Geny Piro; Carmine Carbone; Giampaolo Tortora; Luca Boldrini; Antonella Pietragalla; Gennaro Daniele; Maria Tredicine; Alfredo Cesario; Vincenzo Valentini; Daniela Gallo; Gabriele Babini; Marika D'Oria; Giovanni Scambia
Journal:  J Pers Med       Date:  2021-03-18

9.  Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density.

Authors:  Benedetta Bendinelli; Alessia Vignoli; Domenico Palli; Melania Assedi; Daniela Ambrogetti; Claudio Luchinat; Saverio Caini; Calogero Saieva; Paola Turano; Giovanna Masala
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

Review 10.  Prospects and challenges of cancer systems medicine: from genes to disease networks.

Authors:  Mohammad Reza Karimi; Amir Hossein Karimi; Shamsozoha Abolmaali; Mehdi Sadeghi; Ulf Schmitz
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.